申请人:Aktiebolaget Hässle
公开号:EP0095451A2
公开(公告)日:1983-11-30
New compounds useful as therapeutical agent and useful as intermediates for the preparation of other therapeutically active dihydropyridines, which new compounds are of the formula
wherein R' is one or two (the same or different) substituents on the phenyl ring selected from the group consisting of lower alkyl, NO2, CN. CF,, Ci and Br; A is a straight or branched alkylene group with 2-5 carbon atoms; R2 is
wherein B is a straight or branched alkylene group with 2-5 carbon atoms and R3 and R6 are the same or different and each represents a straight or branched alkyl group with 1-5 carbon atoms, an alkylaryl group or both together are part of a 5-7 membered heterocyclic ring; R4 is a straight or branched alkyl group with 1-5 carbon atoms in which alkyl group the carbon chain is interrupted by an oxygen atom; R5 is a lower alkyl group, or a physiologically acceptable salt or optical isomer thereof, processes for the preparation of said compounds; pharmaceutical preparations containing said compounds, a method for their therapeutical use and a new process using said compounds as intermediates.
可用作治疗剂和制备其他具有治疗活性的二氢吡啶的中间体的新化合物, 这些新化合物的结构式为
其中 R'是苯基环上的一个或两个(相同或不同)取代基,选自由低级烷基、NO2、CN.CF、Ci 和 Br;A 是具有 2-5 个碳原子的直链或支链亚烷基;R2 是
其中,B 是具有 2-5 个碳原子的直链或支链亚烷基,R3 和 R6 相同或不同,且各自代表具有 1-5 个碳原子的直链或支链烷基、烷芳基,或两者都是 5-7 个成员的杂环的一部分;R4 是具有 1-5 个碳原子的直链或支链烷基,其中烷基的碳链被氧原子打断;R5是低级烷基,或其生理上可接受的盐或光学异构体,制备所述化合物的工艺;含有所述化合物的药物制剂,其治疗用途的方法,以及使用所述化合物作为中间体的新工艺。